Calidi Biotherapeutics CLDI
NYSE CLDI
$0.71 -0.05 (-6.60%)
As of: Oct 22, 2026 · 12:18 PM EDT

Calidi Biotherapeutics (CLDI) Short term Debt (2022 - 2024)

Updated

Calidi Biotherapeutics' Short term Debt came in at $223,000 for Q4 2024, up 2.8% from the prior quarter.

Analysis

Calidi Biotherapeutics (CLDI) Short term Debt (2022 - 2024) Analysis & Trends

Going back to Q4 2022, Calidi Biotherapeutics' Short term Debt data covers 6 quarters.

  • Going back by year, Short term Debt was $1 million in FY2022.
  • The Q4 2024 figure represents the highest quarterly Short term Debt since Q3 2023.
  • Business Quant data shows CLDI's Short term Debt at $217,000 (Q3 2024), $211,000 (Q2 2024) and $205,000 (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.71 Bn 1,141.30 Bn 19.71 Bn
2 Johnson & Johnson 643.11 Bn 561.64 Bn 17.26 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 302.74 Bn 266.73 Bn 11.24 Bn
6 Astrazeneca 268.89 Bn 242.58 Bn 12.86 Bn
7 Amgen 242.17 Bn 197.57 Bn 7.24 Bn
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn
10 Calidi Biotherapeutics 1.01 Mn -24.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 223,000.00
Sep 30, 2024 217,000.00
Jun 30, 2024 211,000.00
Mar 31, 2024 205,000.00
Sep 30, 2023 1.00 Mn
Dec 31, 2022 1.00 Mn
API Access

Calidi Biotherapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CLDI&period=max&api_key=YOUR_API_KEY